T0	Outcomes 355 374	safety and efficacy
T1	Outcomes 1028 1182	primary end point was noninferiority of 9-month target vessel failure defined as cardiac death, myocardial infarction, or target vessel revascularization.
T2	Outcomes 1321 1342	target vessel failure
T3	Outcomes 1425 1462	periprocedural myocardial infarctions
T4	Outcomes 1587 1678	cardiac death, myocardial infarction, target vessel revascularization, or stent thrombosis.
T5	Outcomes 1709 1750	binary angiographic in-segment restenosis
T6	Outcomes 1850 1881	target lesion revascularization